| John Taylor Symons, MD | |
|
1 New Beginnings Road, Williamsburg, PA 16693 | |
| (814) 832-2131 | |
| (814) 832-2133 |
| Full Name | John Taylor Symons |
|---|---|
| Gender | Male |
| Speciality | Family Medicine - Addiction Medicine |
| Location | 1 New Beginnings Road, Williamsburg, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659580348 | NPI | - | NPPES |
| 106082 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QA0401X | Family Medicine - Addiction Medicine | MD023792E (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| John Taylor Symons, MD Po Box B, Williamsburg, PA 16693 Ph: (814) 832-2131 | John Taylor Symons, MD 1 New Beginnings Road, Williamsburg, PA 16693 Ph: (814) 832-2131 |
News Archive
Bronchiectasis is independently associated with an increased mortality risk in patients with moderate-to-severe COPD, according to a new study from researchers in Spain.
Cancer researchers at Roswell Park Cancer Institute have identified two independent classes of novel candidate prognostic markers for ovarian cancer, advancing efforts to develop targeted therapies for the disease. The findings resulted from two separate studies published in the peer-reviewed journal PLoS ONE and based on data from The Cancer Genome Atlas (TCGA), the world's largest public database on gene expression in different tumor types.
ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of brain and other cancers, announced today that it has filed a provisional patent application at US Patent Office seeking protection of intellectual property relating to novel glycosylated epitopes present in lung cancer, pancreatic cancer and colon cancer that are targeted by the Company's ICT-109 monoclonal antibody product candidate.
New treatment regimens for multidrug-resistant tuberculosis (MDR-TB) have shown early effectiveness in 85 percent of patients in a cohort that included many people with serious comorbidities that would have excluded them from clinical trials, according to the results of a new international study.
Among the select few physicians honored with the prestigious Patients' Choice Award this year is Dr. Gilbert Webb.
› Verified 6 days ago
Fiona Mclellan, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 306 Plum St, Williamsburg, PA 16693 Phone: 814-832-3405 | |
Laura J Siems, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 306 Plum St, Williamsburg, PA 16693 Phone: 814-832-3405 Fax: 814-832-3811 | |
Jacqulin Fabina, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 306 Plum St, Williamsburg, PA 16693 Phone: 814-832-3405 |